NAD+ Pre Mixed Pen Injector, 500mg
Misc (Generics)
Peptides; weight-loss and aesthetic productsNAD+ (nicotinamide adenine dinucleotide) pre-mixed pen injector; peptide research product
Certifications
- No MHRA marketing authorisation (PL number), EMA European Public Assessment Report (EPAR), or other medicinal product registration has been identified for this NAD+ pre Mixed pen injector.
- NAD+ pre Mixed pen products from peptide suppliers are described as research peptides for in vitro and laboratory use only, emphasising that they are not licensed medicines, foods or cosmetics and must not be used for human or animal administration.
- No CE or UKCA medical device certification details, notified body numbers, or related technical documentation for this specific NAD+ 500 mg pre Mixed pen injector are publicly available.
- Derma Filler Ltd presents itself as a UK Based aesthetics retailer supplying dermal fillers and aesthetic products; no statements are published indicating that this NAD+ pre Mixed pen injector is manufactured in an MHRA Licensed facility or holds medicinal or device approvals.
- No MHRA marketing authorisation (PL number), EMA European Public Assessment Report (EPAR), or other medicinal product registration has been identified for this NAD+ pre Mixed pen injector.
- NAD+ pre Mixed pen products from peptide suppliers are described as research peptides for in vitro and laboratory use only, emphasising that they are not licensed medicines, foods or cosmetics and must not be used for human or animal administration.
- No CE or UKCA medical device certification details, notified body numbers, or related technical documentation for this specific NAD+ 500 mg pre Mixed pen injector are publicly available.
- Derma Filler Ltd presents itself as a UK Based aesthetics retailer supplying dermal fillers and aesthetic products; no statements are published indicating that this NAD+ pre Mixed pen injector is manufactured in an MHRA Licensed facility or holds medicinal or device approvals.
NAD+ (nicotinamide adenine dinucleotide) pre-mixed pen injector; peptide research product
Description
NAD+ Pre-mixed Pen Injector, 500mg is a pre-mixed pen injector product containing 500 mg of NAD+ (nicotinamide adenine dinucleotide) offered by Derma Filler Ltd, a UK-based online aesthetics retailer. The product is listed in the store’s peptide and weight-loss categories and is presented in a pen-style injectable format. Publicly available listings from peptide suppliers indicate that NAD+ pre-mixed pens contain NAD+ in a pre-dosed injector device and are typically marketed as peptide / research products rather than licensed medicines, with some suppliers explicitly restricting their NAD+ pre-mixed pens to in vitro and laboratory research use and stating that they are not drugs, foods, or cosmetics and must not be introduced into humans or animals. No detailed product-specific description or clinical claims are provided on the Derma Filler Ltd product page beyond the name, strength, price and category placement.
Bnefits
- Provides NAD+ (nicotinamide adenine dinucleotide) in a 500 mg pre-mixed pen injector format.
- Offered by an aesthetics-focused retailer within peptide and weight-loss product categories, allowing procurement alongside other aesthetic and wellness products.
- Pre-mixed pen injector presentation is designed to provide pre-dosed NAD+ solution in a pen-type device rather than as separate vials and diluents.
- Comparable NAD+ pre-mixed pen products from peptide suppliers are marketed for research and experimental use, providing a pre-formulated NAD+ preparation for such purposes.
Indications
- No licensed medicinal indications are listed for this product.
- Product is sold as a peptide / aesthetic / weight-loss item rather than as a licensed medicine.
- Comparable NAD+ pre-mixed pen products from peptide suppliers are described as being for research use only and not for human or animal administration.
Composition
- Active component: NAD+ (nicotinamide adenine dinucleotide), 500 mg total per pre-mixed pen injector (as stated in the product name and matching strengths on other NAD+ pre-mixed pen listings).
- The specific solvent, excipients, buffer components, concentration per millilitre, and detailed formulation of the solution in the pen injector are not publicly listed for this product.
- No official certificate of analysis, excipient list, or detailed chemical specification for this particular 500 mg pen injector from Derma Filler Ltd is publicly available.
Formulation
- Pre-mixed pen injector containing NAD+ (nicotinamide adenine dinucleotide) solution, with a declared total content of 500 mg NAD+ per pen.
- Pen-style injector device intended to deliver pre-mixed NAD+ solution; the exact volume of solution, concentration, and device specifications are not publicly listed for the Derma Filler Ltd presentation.
- Publicly available information from other NAD+ pre-mixed pen listings confirms that this format is offered as a pre-formulated NAD+ pen rather than a lyophilised powder vial.
Packaging
- Supplied as a single pre-mixed pen injector device in primary packaging (pen body with integral reservoir); detailed labelling text and secondary packaging (box, leaflet) are not publicly shown for the Derma Filler Ltd listing.
- The product image shows a pen-type injector; no additional information on packaging materials, tamper-evident features, or pack sizes beyond a single pen is publicly provided.
- No information is publicly listed on any included accessories (such as needles, alcohol swabs, or instructions) specific to this 500 mg pen injector.
Usage
- No specific dosing or administration instructions for this 500 mg pen injector are publicly listed by Derma Filler Ltd.
- The Derma Filler Ltd website operates as an aesthetics and dermal filler retailer and does not provide detailed NAD+ pen protocols on the publicly accessible product snippet.
- Comparable Euro-Gen NAD+ pre-mixed pen products sold by peptide suppliers are described as peptides intended for research use only, with explicit statements that they are not drugs, foods or cosmetics, are for in vitro and laboratory research purposes, and must not be introduced into humans or animals; these statements apply to those suppliers’ products and illustrate the general regulatory positioning of such NAD+ pre-mixed pen injectors.
- Any specific instructions for use, dose titration, or administration route applicable to this Derma Filler Ltd product are not publicly disclosed and cannot be verified from available sources.
Contraindications
- Not publicly listed (no formal contraindication list comparable to a medicinal product SmPC is published for this NAD+ pre-mixed pen injector).
- Peptide suppliers offering NAD+ pre-mixed pens for research clearly state that their products must not be administered to humans or animals, implying that any clinical use would fall outside the stated intended use and regulatory position of such products.
Adverse Effects
- Not publicly listed (no structured adverse reaction profile or safety table specific to this NAD+ pre-mixed pen injector is provided by Derma Filler Ltd or in other publicly accessible regulatory documentation).
Storage Conditions
- Not publicly listed for this specific 500 mg pen injector on the Derma Filler Ltd site.
- General storage instructions for other NAD+ peptide products (including NAD+ pre-mixed pens and research peptides) commonly refer to cool storage and protection from light, but no product-specific, verifiable storage data (temperature range, shelf life, in-use stability) are published for this particular item.
Duration
Not publicly listed
Onset
Not publicly listed
